TrianglePUBLICATIONS · 8604245
Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Oncology
- Publication date
- 1996 Mar-Apr
- First author
- Furuse K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Furuse K
- type
- Author
- name
- Kubota K
- type
- Author
- name
- Kawahara M
- type
- Author
- name
- Takada M
- type
- Author
- name
- Kimura I
- type
- Author
- name
- Fujii M
- type
- Author
- name
- Ohta M
- type
- Author
- name
- Hasegawa K
- type
- Author
- name
- Yoshida K
- type
- Author
- name
- Nakajima S
- type
- Author
- name
- Ogura T
- type
- Author
- name
- Niitani H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Furuse K
- type
- Author
- name
- Kubota K
- type
- Author
- name
- Kawahara M
- type
- Author
- name
- Takada M
- type
- Author
- name
- Kimura I
- type
- Author
- name
- Fujii M
- type
- Author
- name
- Ohta M
- type
- Author
- name
- Hasegawa K
- type
- Author
- name
- Yoshida K
- type
- Author
- name
- Nakajima S
- type
- Author
- name
- Ogura T
- type
- Author
- name
- Niitani H
- type
- Author
- bibliography ids
- nci-bib-ff7c83e8810531c6c10925e4
- book metadata
- content sha256
- 800785438d8a13b1cbf64bcdd0078e1cce383c5f20bbd49859299b3219d9c381
- document type
- citation
- dois
- 10.1159/000227555
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8604245
- immutable id
- pubmed:8604245@800785438d8a13b1cbf64bcdd0078e1cce383c5f20bbd49859299b3219d9c381
- journal
- abbreviation
- Oncology
- issn electronic
- Source null
- issn print
- 0030-2414
- issue
- 2
- name
- Oncology
- nlm unique id
- 0135054
- pages
- 169-72
- volume
- 53
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8604245
- provenance
- batch id
- 6de860041cedd40f623b
- provider
- NCBI PubMed ESummary
- record sha256
- f884ff8ef8caa2009c011b581cc980e9f516765a4835eea140c6cf0b63b47c66
- response sha256
- f46103bbddb69bd5f2ea5fd2e8d9cab75a19eeb01ce2a0d1f98b4d456a872039
- retrieved at
- 2026-09-09T23:45:23.163950+00:00
- publication date
- display
- 1996 Mar-Apr
- precision
- range_or_season
- year
- 1996
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8604245/
- title
- Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group.
Preserved source evidence · Not medical advice